VIA EDGAR
August 4, 2020
Office of Life Sciences
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: | Courtney Lindsay | |||
Mary Beth Breslin |
Re: | Checkmate Pharmaceuticals, Inc. |
Acceleration Request for Registration Statement on Form S-1 |
File No. 333-239932 |
Requested Date: | August 6, 2020 | |||
Requested Time: | 4:00 p.m. Eastern Standard Time |
Dear Mr. Lindsay and Ms. Breslin:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Checkmate Pharmaceuticals, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to August 6, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Carolyn Ward at (617) 570-1376. We also respectfully request that a copy of the written order from the Securities and Exchange Commission (the “Commission”) verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: Carolyn Ward, by facsimile to (617) 801-8979.
[Remainder of page left intentionally blank]
If you have any questions regarding this request, please contact Carolyn Ward of Goodwin Procter LLP at (617) 570-1376.
Sincerely, |
CHECKMATE PHARMACEUTICALS, INC. |
/s/ Barry Labinger |
Barry Labinger |
President and Chief Executive Officer |
cc: | Kleem Chaudhary, Chief Business Officer, Checkmate Pharmaceuticals, Inc. |
Jon Lieber, Chief Financial Officer, Checkmate Pharmaceuticals, Inc.
Benjamin K. Marsh, Esq., Goodwin Procter LLP
[Signature Page to Acceleration Request]